ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,741,639 | -11.9% | 248,402 | -0.3% | 0.30% | -7.8% |
| Q2 2023 | $7,655,380 | +4.7% | 249,036 | +22.7% | 0.32% | -2.7% |
| Q1 2023 | $7,312,722 | +74.7% | 202,962 | +91.6% | 0.33% | +67.0% |
| Q4 2022 | $4,186,630 | -1.7% | 105,937 | -0.0% | 0.20% | -11.3% |
| Q3 2022 | $4,258,000 | -4.4% | 105,953 | +0.0% | 0.22% | -4.3% |
| Q2 2022 | $4,454,000 | -3.6% | 105,937 | -10.6% | 0.23% | +23.4% |
| Q1 2022 | $4,619,000 | +36.9% | 118,556 | +40.0% | 0.19% | +39.3% |
| Q4 2021 | $3,375,000 | – | 84,704 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |